Stay updated on Pembrolizumab for Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Biliary Tract Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3 on the page, indicating a new version label. This represents a minor update to the document's revision history without altering substantive content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.5.2 has been added and v3.5.0 has been removed. This is a minor maintenance update that does not affect study details or user-facing content.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-status notice and the previous Revision: v3.4.1.SummaryDifference0.4%

- Check92 days agoChange DetectedAdded a government funding lapse notice banner. Updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.